We are studying novel tocotrienols, which have a number of activities that
might interfere with the formation of atherosclerotic placques, including h
ypocholesterolemic, antioxidant, anti-inflammatory and antiproliferation ef
fects. This study compared the effects of alpha -tocopherol, the tocotrieno
l-rich fraction (TRF25) and didesmethyl tocotrienol (d-P-25-T3) of rice bra
n on the pathogenesis of atherosclerotic lesions in C57BL/6 apolipoprotein
(apo)E-deficient (-/-) mice. These mice are an excellent model because they
become hyperlipidemic even when they consume a low fat diet and they devel
op complex atherosclerotic lesions similar to those of humans. These compou
nds were also tested in wild-type C57BL/6 apoE (+/+) and (+/-) mice fed low
or high fat diets. When a high fat diet was supplemented with alpha -tocop
herol, TRF25 or d-P-25-T3 and fed to mice (+/+) for 24 wk, atherosclerotic
lesion size was reduced 23% (P = 0.33), 36% (P = 0.14) and 57% (P < 0.02),
respectively, and in mice (+/-) fed for 18 wk, lesions were reduced by 19%
(P = 0.15), 28% (P < 0.01) and 33% (P < 0.005), respectively, compared with
mice fed a control diet. A low fat diet did not cause atherosclerotic lesi
ons in these mice. The low fat diet supplemented with TRF25 or d-P25-T3 fed
to apoE-deficient (-/-) mice for 14 wk decreased atherosclerotic lesion si
ze by 42% (P < 0.04) and 47% (P < 0.01), respectively, whereas alpha -tocop
herol supplementation resulted in only an 11% (P = 0.62) reduction. These r
esults demonstrate the superior efficacy of tocotrienols compared with alph
a -tocopherol. Although tocotrienols decreased serum triglycerides, total a
nd LDL cholesterol levels, the decreases in atherosclerotic lesions seem to
be due to the other activities. Serum tocol concentrations in various grou
ps are also described. This is the first report of a significant reduction
in the atherosclerotic lesion size in all three genotypes of apoE mice fed
a novel tocotrienol (d-P-25-T3) of rice bran. Dietary tocotrienol supplemen
ts may provide a unique approach to promoting cardiovascular health.